Application of corydalis tuber extract in preparation of anti-anaphylactoid drugs

The invention discloses application of a rhizoma corydalis extract in preparation of an anti-anaphylactoid drug, and belongs to the technical field of preparation of the anti-anaphylactoid drug. By comparing P815 cell degranulation and inflammatory factor release, mouse local skin anaphylactoid reaction inflammatory infiltration degree and mouse systemic allergy symptoms, the treatment effect of the medicine on anaphylactoid diseases is evaluated, and it is determined that the rhizoma corydalis extract can be used for preparing the anti-anaphylactoid medicine. The rhizoma corydalis extract can effectively relieve local and systemic anaphylactoid reaction symptoms of mice; and mast cell degranulation is reduced, and symptoms caused by anaphylactoid are remarkably improved..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 08. Dez. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

HE LANGCHONG [VerfasserIn]
HAN SHENGLI [VerfasserIn]
HE HUAIZHEN [VerfasserIn]
WANG NAN [VerfasserIn]
MA WEINA [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-12-08, Last update posted on www.tib.eu: 2024-03-04, Last updated: 2024-03-08

Patentnummer:

CN117180334

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA019325525